CXCL9, 10, 11/CXCR3 Axis Contributes to the Progress of Primary Sjogren’s Syndrome by Activating GRK2 to Promote T Lymphocyte Migration

Brito-Zerón, P., C. Baldini, H. Bootsma, S.J. Bowman, R. Jonsson, X. Mariette, K. Sivils, E. Theander, A. Tzioufas, and M. Ramos-Casals. 2016. Sjögren syndrome. Nature Reviews Disease Primers

Stefanski, A.L., C. Tomiak, U. Pleyer, T. Dietrich, G.R. Burmester, and T. Dorner. 2017. The Diagnosis and Treatment of Sjogren’s Syndrome. Deutsches Ärzteblatt International 114: 354–361.

PubMed  PubMed Central  Google Scholar 

Both, T., V.A.S.H. Dalm, P.M. van Hagen, and P.L.A. van Daele. 2017. Reviewing primary Sjögren’s syndrome: Beyond the dryness - From pathophysiology to diagnosis and treatment. International Journal of Medical Sciences 14: 191–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao, Y., J. Ma, C. Chang, T. Xu, C. Gao, M.E. Gershwin, and Z. Lian. 2021. Immunobiology of T Cells in Sjögren’s Syndrome. Clinical Reviews in Allergy & Immunology 60: 111–131.

Article  CAS  Google Scholar 

Verstappen, G.M., S. Pringle, H. Bootsma, and F. Kroese. 2021. Epithelial-immune cell interplay in primary Sjogren syndrome salivary gland pathogenesis. Nature Reviews Rheumatology 17: 333–348.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nikolov, N.P., and G.G. Illei. 2009. Pathogenesis of Sjögren’s syndrome. Current Opinion in Rheumatology 21: 465–470.

Article  PubMed  PubMed Central  Google Scholar 

Ogawa, Y., E. Shimizu, and K. Tsubota. 2018. Interferons and Dry Eye in Sjögren’s Syndrome. International Journal of Molecular Sciences 19: 3548.

Article  PubMed  PubMed Central  Google Scholar 

Van Raemdonck, K., P.E. Van den Steen, S. Liekens, J. Van Damme, and S. Struyf. 2015. CXCR3 ligands in disease and therapy. Cytokine & Growth Factor Reviews 26: 311–327.

Article  Google Scholar 

Yoon, K.C., C.S. Park, I.C. You, H.J. Choi, K.H. Lee, S.K. Im, H.Y. Park, and S.C. Pflugfelder. 2010. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Investigative Ophthalmology & Visual Science 51: 643–650.

Article  Google Scholar 

James, J.A., J.M. Guthridge, H. Chen, R. Lu, R.L. Bourn, K. Bean, M.E. Munroe, M. Smith, E. Chakravarty, A.N. Baer, G. Noaiseh, A. Parke, K. Boyle, L. Keyes-Elstein, A. Coca, T. Utset, M.C. Genovese, V. Pascual, P.J. Utz, V.M. Holers, K.D. Deane, K.L. Sivils, T. Aberle, D.J. Wallace, J. McNamara, N. Franchimont, and St. Clair, E.W. 2020. Unique Sjögren’s syndrome patient subsets defined by molecular features. Rheumatology 59: 860–868.

Article  CAS  PubMed  Google Scholar 

Antonelli, A., S.M. Ferrari, D. Giuggioli, E. Ferrannini, C. Ferri, and P. Fallahi. 2014. Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmunity Reviews 13: 272–280.

Article  CAS  PubMed  Google Scholar 

Panzer, U., G. Zahner, U. Wienberg, O.M. Steinmetz, A. Peters, J.E. Turner, H.J. Paust, G. Wolf, R.A.K. Stahl, and A. Schneider. 2008. 15-Deoxy- 12,14-prostaglandin J2 inhibits INF- -induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrology Dialysis Transplantation 23: 3776–3785.

Article  CAS  Google Scholar 

Barrera, M., S. Aguilera, I. Castro, S. Matus, P. Carvajal, C. Molina, S. González, D. Jara, M. Hermoso, and M. González. 2021. Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: Implications in Sjögren’s syndrome. Rheumatology 60: 1951–1962.

Article  CAS  PubMed  Google Scholar 

Eiger, D.S., N. Boldizsar, C.C. Honeycutt, J. Gardner, S. Kirchner, C. Hicks, I. Choi, U. Pham, K. Zheng, A. Warman, J.S. Smith, J.Y. Zhang, and S. Rajagopal. 2022. Location bias contributes to functionally selective responses of biased CXCR3 agonists. Nature Communications 13.

Satarkar, D., and Patra, C. 2022. Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review. Frontiers in Cell and Developmental Biology 10.

Zhou, J., and Q. Yu. 2018. Disruption of CXCR3 function impedes the development of Sjögren’s syndrome-like xerostomia in non-obese diabetic mice. Laboratory Investigation 98: 620–628.

Article  CAS  PubMed  Google Scholar 

Allred, M., M.S. Chimenti, A.E. Ciecko, Y. Chen, and S.M. Lieberman. 2021. Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice. International Journal of Molecular Sciences 22: 3767.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tokunaga, R., W. Zhang, M. Naseem, A. Puccini, M.D. Berger, S. Soni, M. McSkane, H. Baba, and H. Lenz. 2018. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews 63: 40–47.

Article  CAS  PubMed  Google Scholar 

Palmer, C.B., G. D’Uonnolo, R. Luís, M. Meyrath, T. Uchański, A. Chevigné, and M. Szpakowska. 2022. Nanoluciferase-based complementation assay for systematic profiling of GPCR-GRK interactions. Methods in Cell Biology 169: 309–321.

Article  CAS  PubMed  Google Scholar 

Smith, J.S., P. Alagesan, N.K. Desai, T.F. Pack, J. Wu, A. Inoue, N.J. Freedman, and S. Rajagopal. 2017. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways. Molecular Pharmacology 92: 136–150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scuron, M.D., B. Fay, J. Oliver, and P. Smith. 2019. Spontaneous Model of Sjögren’s Syndrome in NOD Mice. Current Protocols in Pharmacology 86.

Bautista-Vargas, M., A.J. Vivas, and G.J. Tobón. 2020. Minor salivary gland biopsy: Its role in the classification and prognosis of Sjögren’s syndrome. Autoimmunity Reviews 19: 102690.

Article  PubMed  Google Scholar 

Nocturne, G., and X. Mariette. 2013. Advances in understanding the pathogenesis of primary Sjogren’s syndrome. Nature Reviews Rheumatology 9: 544–556.

Article  CAS  PubMed  Google Scholar 

Sarkar, I., R. Davies, A.K. Aarebrot, S.M. Solberg, A. Petrovic, A.M. Joshi, B. Bergum, J.G. Brun, D. Hammenfors, R. Jonsson, and S. Appel. 2022. Aberrant signaling of immune cells in Sjögren’s syndrome patient subgroups upon interferon stimulation. Frontiers in Immunology 13.

Grange, L., E. Chalayer, D. Boutboul, S. Paul, L. Galicier, B. Gramont, and M. Killian. 2022. TAFRO syndrome: A severe manifestation of Sjogren’s syndrome? A systematic review. Autoimmun Rev 21: 103137.

Article  CAS  PubMed  Google Scholar 

Bombardieri, M., O.D. Argyropoulou, F. Ferro, R. Coleby, E. Pontarini, G. Governato, D. Lucchesi, G. Fulvio, A.G. Tzioufas, and C. Baldini. 2020. One year in review 2020: Pathogenesis of primary Sjogren’s syndrome. Clinical and Experimental Rheumatology 38 (Suppl 126): 3–9.

PubMed  Google Scholar 

Negrini, S., G. Emmi, M. Greco, M. Borro, F. Sardanelli, G. Murdaca, F. Indiveri, and F. Puppo. 2022. Sjögren’s syndrome: A systemic autoimmune disease. Clinical and Experimental Medicine 22: 9–25.

Article  CAS  PubMed  Google Scholar 

Nezos, A., F. Gravani, A. Tassidou, E.K. Kapsogeorgou, M. Voulgarelis, M. Koutsilieris, M.K. Crow, and C.P. Mavragani. 2015. Type I and II interferon signatures in Sjogren’s syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren’s related lymphomagenesis. Journal of Autoimmunity 63: 47–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall, J.C., A.N. Baer, A.A. Shah, L.A. Criswell, C.H. Shiboski, A. Rosen, and L. Casciola-Rosen. 2015. Molecular Subsetting of Interferon Pathways in Sjögren’s Syndrome. Arthritis & Rheumatology 67: 2437–2446.

Article  CAS  Google Scholar 

Hall, J.C., L. Casciola-Rosen, A.E. Berger, E.K. Kapsogeorgou, C. Cheadle, A.G. Tzioufas, A.N. Baer, and A. Rosen. 2012. Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proceedings of the National Academy of Sciences 109: 17609–17614.

Article  CAS  Google Scholar 

Voynova, E., F. Lefebvre, A. Qadri, and S. Muller. 2020. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren’s syndrome. Journal of Autoimmunity 108, 102418.

Yu, S., L. Sun, Y. Jiao, and L.T.O. Lee. 2018. The Role of G Protein-coupled Receptor Kinases in Cancer. International Journal of Biological Sciences 14: 189–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiménez-Sainz, M.C., C. Murga, A. Kavelaars, M. Jurado-Pueyo, B.F. Krakstad, C.J. Heijnen, F.J. Mayor, and A.M. Aragay. 2006. G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits. Molecular Biology of the Cell 17: 25–31.

Article  PubMed  PubMed Central  Google Scholar 

Liampas, A., K. Parperis, M.F. Erotocritou, A. Nteveros, M. Papadopoulou, C. Moschovos, M. Akil, S. Coaccioli, G.M. Hadjigeorgiou, M. Hadjivassiliou, and P. Zis. 2022. Primary Sjögren syndrome‐related peripheral neuropathy: A systematic review and meta‐analysis. European Journal of Neurology.

Zhao, J., Q. An, X. Zhu, B. Yang, X. Gao, Y. Niu, L. Zhang, K. Xu, and D. Ma. 2022. Research status and future prospects of extracellular vesicles in primary Sjögren’s syndrome. Stem Cell Research and Therapy 13.

留言 (0)

沒有登入
gif